Pharmacist knowledge of gout management: impact of an educational intervention.
Crystal arthritis
Education
Gout
Multi-disciplinary care
Journal
BMC rheumatology
ISSN: 2520-1026
Titre abrégé: BMC Rheumatol
Pays: England
ID NLM: 101738571
Informations de publication
Date de publication:
23 May 2022
23 May 2022
Historique:
received:
28
11
2021
accepted:
09
03
2022
entrez:
22
5
2022
pubmed:
23
5
2022
medline:
23
5
2022
Statut:
epublish
Résumé
Pharmacists play a key role in community gout education. We investigated pharmacist knowledge of gout management and developed an educational intervention which was assessed in a cohort of Irish pharmacists. A ten-question questionnaire about gout management was developed to assess pharmacists' knowledge. A 14 min 26 s video educational intervention was co-designed by a rheumatologist, a pharmacist, and designer of pharmacy education resources. The effectiveness of this pharmacy-specific intervention was assessed using the same questionnaire in 53 pharmacists (25 in the intervention group; 28 in the control group). Contingency tables were used to analyse differences between groups. There were 173 pharmacist respondents to the initial survey; 35.3% answered that first-line therapy for gout involves a combination of a xanthine oxidase inhibitor (e.g., allopurinol) combined with a prophylactic agent (e.g., colchicine), and 28.9% of respondents answered that colchicine prophylaxis should be used when initiating urate-lowering therapy. Following the educational intervention, pharmacist's knowledge about gout management increased across many domains, including serum urate targets when using urate-lowering therapy (p = 0.006), use of colchicine prophylaxis (p = 0.011), and duration of colchicine use (p < 0.001). Gout management recommendations can be impeded if translation into pharmacy practice is neglected. Pharmacists are a valuable information resource for patients. Co-designing a brief education intervention with pharmacists is an effective, low-cost way to increase pharmacist knowledge on the management of gout.
Sections du résumé
BACKGROUND
BACKGROUND
Pharmacists play a key role in community gout education. We investigated pharmacist knowledge of gout management and developed an educational intervention which was assessed in a cohort of Irish pharmacists.
METHODS
METHODS
A ten-question questionnaire about gout management was developed to assess pharmacists' knowledge. A 14 min 26 s video educational intervention was co-designed by a rheumatologist, a pharmacist, and designer of pharmacy education resources. The effectiveness of this pharmacy-specific intervention was assessed using the same questionnaire in 53 pharmacists (25 in the intervention group; 28 in the control group). Contingency tables were used to analyse differences between groups.
RESULTS
RESULTS
There were 173 pharmacist respondents to the initial survey; 35.3% answered that first-line therapy for gout involves a combination of a xanthine oxidase inhibitor (e.g., allopurinol) combined with a prophylactic agent (e.g., colchicine), and 28.9% of respondents answered that colchicine prophylaxis should be used when initiating urate-lowering therapy. Following the educational intervention, pharmacist's knowledge about gout management increased across many domains, including serum urate targets when using urate-lowering therapy (p = 0.006), use of colchicine prophylaxis (p = 0.011), and duration of colchicine use (p < 0.001).
CONCLUSION
CONCLUSIONS
Gout management recommendations can be impeded if translation into pharmacy practice is neglected. Pharmacists are a valuable information resource for patients. Co-designing a brief education intervention with pharmacists is an effective, low-cost way to increase pharmacist knowledge on the management of gout.
Identifiants
pubmed: 35599318
doi: 10.1186/s41927-022-00259-x
pii: 10.1186/s41927-022-00259-x
pmc: PMC9125937
doi:
Types de publication
Journal Article
Langues
eng
Pagination
30Subventions
Organisme : A.Menarini Pharmaceuticals Ireland
ID : Educational Grant
Informations de copyright
© 2022. The Author(s).
Références
Arthritis Care Res (Hoboken). 2020 Jun;72(6):744-760
pubmed: 32391934
Psychol Sci. 2014 Mar;25(3):639-47
pubmed: 24444515
Ann Fam Med. 2018 Nov;16(6):515-520
pubmed: 30420366
BMJ Open. 2018 Apr 10;8(4):e017542
pubmed: 29643150
Am J Med. 2019 Mar;132(3):354-361
pubmed: 30503879
Addict Sci Clin Pract. 2019 Sep 2;14(1):30
pubmed: 31474225
Ann Rheum Dis. 2017 Jan;76(1):29-42
pubmed: 27457514
Pharmacy (Basel). 2019 Sep 25;7(4):
pubmed: 31557795
J Clin Rheumatol. 2011 Aug;17(5):242-8
pubmed: 21778899
Nat Rev Rheumatol. 2015 Nov;11(11):649-62
pubmed: 26150127
Int J Qual Health Care. 2003 Jun;15(3):261-6
pubmed: 12803354
Lancet. 2016 Oct 22;388(10055):2039-2052
pubmed: 27112094
Public Health. 1992 May;106(3):231-7
pubmed: 1603927
Nat Rev Dis Primers. 2019 Sep 26;5(1):69
pubmed: 31558729